Home › Funds › GSA CAPITAL PARTNERS LLP › TECH
GSA CAPITAL PARTNERS LLP position in TECH
BIO-TECHNE CORP · Health Care
GSA CAPITAL PARTNERS LLP reported holding 44,565 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 0.19% of its reported portfolio and ranking #50 among its reported holdings. GSA CAPITAL PARTNERS LLP has disclosed TECH holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GSA CAPITAL PARTNERS LLP's TECH position evolved
GSA CAPITAL PARTNERS LLP first disclosed a stake in TECH in Q3 2023 at 5,102 shares (US$347K). The position peaked in Q3 2026 at 44,565 shares, worth US$3.2M. Across 6 filings, GSA CAPITAL PARTNERS LLP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 44,565 shares valued at US$3.2M — an increase of 39,278 shares quarter over quarter.. Notable position changes include a 49% increase in Q3 2025 (shares rose 6% over the following quarter), a 743% increase in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.10K | $347.00K | New |
| Q2 2025 | 5.23K | $269.00K | New |
| Q3 2025 | 7.80K | $434.00K | Add |
| Q1 2026 | 5.10K | $267.00K | New |
| Q2 2026 | 5.29K | $374.00K | Add |
| Q3 2026 | 44.56K | $3.23M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 24 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$560.3M), Ruane Cunniff & Goldfarb (Sequoia) (US$242.3M), Qube Research & Technologies Ltd (US$172.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 7.73M sh · $560.35M · Q3 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.34M sh · $242.26M · Q3 2026
- Qube Research & Technologies Ltd 2.38M sh · $172.44M · Q3 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on GSA CAPITAL PARTNERS LLP
FAQ
How long has GSA CAPITAL PARTNERS LLP held TECH?
GSA CAPITAL PARTNERS LLP has disclosed TECH holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is GSA CAPITAL PARTNERS LLP's current position in TECH?
As of Q3 2026, GSA CAPITAL PARTNERS LLP holds 44.56K shares of TECH (BIO-TECHNE CORP), valued at $3.23M, representing 0.19% of its reported portfolio and ranking #50.
Has GSA CAPITAL PARTNERS LLP been buying or selling TECH?
In the latest 13F filing (Q3 2026), GSA CAPITAL PARTNERS LLP increased its position in TECH. The position peaked in Q3 2026 at 44.56K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), Qube Research & Technologies Ltd, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.